H. Tanaka

发表

Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma.

H. Asaoku, T. Hirano, T. Kishimoto, 1988, Blood.

Phenotypic difference of normal plasma cells from mature myeloma cells.

H. Asaoku, H. Harada, A. Kuramoto, 1993, Blood.

Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.

H. Asaoku, H. Ishikawa, A. Kuramoto, 1989, Blood.

Interleukin-2-mediated growth of leukemic cells in lymph nodes of patients with adult T-cell leukemia/lymphoma.

T. Fujiyoshi, H. Fujiwara, N. Arima, 1996, Leukemia research.

Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.

H. Asaoku, H. Ishikawa, Y. Ohmoto, 1989, Cancer research.

Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption.

H. Asaoku, H. Ishikawa, A. Kuramoto, 1990, Blood.

Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia.

Y. Yamamoto, N. Arima, S. Ohgaki, 1986, Blood.

The molecular mechanism of inhibition of interleukin-1β-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract

J. Du, H. Kitasato, K. Okamoto, 1999, Inflammation Research.

Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells.

Y. Yamamoto, N. Arima, S. Ohgaki, 1987, Journal of immunology.

A patient with anaplastic large cell lymphoma (Ki-1 lymphoma) showing clonal integration of HTLV-1 proviral DNA.

N. Sasaki, A. Kuramoto, O. Tanabe, 1994, Leukemia.

Granulocyte-colony stimulating factor induces differentiation and apoptosis of CD2, CD7 positive hybrid leukemia cells in vivo and ex vivo.

H. Fujiwara, N. Arima, H. Tanaka, 1997, Leukemia research.

Heterogenous response of B cell chronic lymphocytic leukaemia (B‐CLL) cells to anti‐human IgM antibody (anti‐μ) and B cell stimulatory factor 1 (BSF‐1)

H. Asaoku, H. Ishikawa, A. Kuramoto, 1989, British journal of haematology.

Frequent expression of interleukin-9 mRNA and infrequent involvement of interleukin-9 in proliferation of primary adult T-cell leukemia cells and HTLV-I infected T-cell lines.

H. Fujiwara, N. Arima, H. Tanaka, 1997, Leukemia research.

Pachydermoperiostosis with myelofibrosis and anemia: report of a case of anemia of multifactorial causes and its improvement with steroid pulse and iron therapy.

A. Kuramoto, A. Kimura, A. Sakai, 1991, Japanese journal of medicine.

Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro.

H. Asaoku, A. Kuramoto, K. Iwato, 1988, Blood.

Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma.

H. Asaoku, H. Ishikawa, Y. Ohmoto, 1989, Blood.

Identification of immature and mature myeloma cells in the bone marrow of human myelomas.

H. Harada, A. Sakai, Y. Harada, 1993, Blood.

Relation of autonomous and interleukin-2-responsive growth of leukemic cells to survival in adult T-cell leukemia.

H. Fujiwara, N. Arima, H. Tanaka, 1996, Blood.

Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells.

H. Asaoku, H. Ishikawa, A. Kuramoto, 1989, Blood.

[Ph1 positive myeloblastic crisis followed by Ph1 negative, bcr rearrangement positive T lymphoid crisis in a CML case].

N. Arima, H. Tanaka, K. Matsushita, 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Expression of cadherin-catenin complexes in human leukemia cell lines.

M. Ozawa, N. Arima, J. Tsutsui, 1996, Journal of biochemistry.

Altered expression of Pax-5 gene in human myeloma cells.

M. Nobuyoshi, Hideo Tanaka, M. Kawano, 1996, Blood.